OpenBilldrug price receipt

NADAC week of 2026-10-14

AMIKACIN SULF 500 MG/2 ML VIAL

For 2 mL

Pharmacies pay

$4.66 filed

2 × $2.3276 per ML

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$2.72 filed

2 × $1.35885 per ML, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

The spread

0.58× estimated

Medicare paid 42% less than pharmacies pay.

Part D averages every strength and form sold under “Amikacin Sulfate” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$10.36 estimated

$4.66 + $0.70 (15%) + $5.00 fee per fill = $10.36

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

AMIKACIN SULF 500 MG/2 ML VIAL is how the CMS NADAC file names this product. The FDA NDC Directory lists it as amikacin sulfate.

FDA gives its dosage form as “injection” and “injection, solution” and its route as intramuscular; intravenous.

FDA lists 5 labelers (the companies named on the label) for its NDCs, among them Hikma Pharmaceuticals USA Inc., Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. and Sagent Pharmaceuticals.

FDA’s Established Pharmacologic Class for it is Aminoglycoside Antibacterial.

The NADAC file of 2026-10-14 prices it under 6 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $4.66 for 2 mL (2 × $2.3276 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

What NADAC measures · NADAC explanation codes

All 6 NDCs

Compared with its class

The middle of its 6 NDCs’ NADAC prices is $2.3276 per ML filed.

Of the 15 other products in FDA’s Aminoglycoside Antibacterial class priced per ML, 9 have a higher middle NADAC price and 6 a lower one. The one in the middle is TOBRAMYCIN-DEXAMETH OPHTH SUSP, at $4.1784 per ML filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

Medicare Part D paid $2.72 for 2 mL, at an average of $1.35885 per ML in 2024 (2024-01-01 to 2024-12-31) for “Amikacin Sulfate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 12,540 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for AMIKACIN SULF 500 MG/2 ML VIAL labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Amikacin Sulfate / Amikacin Sulfate: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's ML. Joined on generic name.
Why does this page start at 2 mL?
NADAC prices this product per ML. In the FDA NDC Directory, 6 of this product’s NDCs are wholesale packs of identical units, so OpenBill counts one unit of each; for example, NDC 00641-6167-10 (“10 VIAL, SINGLE-DOSE in 1 CARTON (0641-6167-10) / 2 mL in 1 VIAL, SINGLE-DOSE (0641-6167-01)”) is a carton of 10 vials, 20 mL in all. So the card starts at one unit: 2 ML. Change it to match your prescription.

Its pharmacologic class

Related in the same class

More